TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

SOL - Nicotine Replacement Therapy

Nicotine substitutes
West Midlands (UKG32)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Intelligence
Published evidence · v1
Prepared 7 Sept 2026, 18:08 BST
A pre-calculated analytical view of official UK procurement facts, competition benchmarks and decision timelines.
Bid readiness
Review notice
Submission deadline not published
Check official notice for submission route
Scope structure
1lots
1 lot · 1 published item
1 published CPV family
Decision Velocity
~52 days
Typical sector award window after deadline
Sector median: 52 days
Contract lifecycle
Not published
No future linked contract end in retained records
No published extension signal
Pricing & Budget Savings
£1,400,566
Contract/award value: £1,400,566
1 award supplier linked
Bidding Competition
Not published
SME bid count not published
No bid spread metrics published
Sector Market Benchmark (CPV 33)
Based on 74 published procedures
Median Winning Discount
41.96%
Award reduction below published budget
Typical Bids Received
3 bidders
Median competitive participation in sector
Typical Evaluation Window
52 days
Median time between deadline and award
Top Contenders in this Sector (CPV 33)
Active commercial suppliers winning public contracts in this field
SupplierAwards won in sectorTotal awarded valueAvg. winning discount
Medtronic Limited
42 contracts£11,274,871,284-48.5% below budget
Baxter Healthcare Ltd
40 contracts£2,128,139,644At ceiling / not disclosed
B. Braun Medical Limited
35 contracts£2,136,030,424-59.1% below budget
Teva UK Limited
30 contracts£834,774,799-59.1% below budget
Glenmark Pharmaceuticals Europe Ltd
26 contracts£1,018,605,826-59.1% below budget
NORTHERN HOSPITAL SUPPLIES LTD
23 contracts£6,514,396,855At ceiling / not disclosed
Fannin Limited
23 contracts£3,563,512,187At ceiling / not disclosed
B. Braun Medical Limited
22 contracts£11,516,824,438At ceiling / not disclosed
Martindale Pharma
22 contracts£770,894,756At ceiling / not disclosed
Sandoz Ltd
22 contracts£19,160,715At ceiling / not disclosed
Evidence coverage
5/12 core inputs published
Standard procedure facts
Comparable published opportunities
Historic records ranked from matching published evidence. They are research comparables, not expected competitors or a price forecast.
Published procedurePublished valueMatching evidence
University Hospitals Birmingham Eyecare Voucher ProvisionUniversity Hospitals Birmingham NHS Foundation Trust · 25 Aug 2026, 13:30 BST
£365,000
same CPV family
same region
Nicotine Replacement Therapy and Smoking Cessation Medication Postal Supply within SuffolkSuffolk County Council · 24 Jul 2026, 16:01 BST
£400,000
same CPV family
Continuous Renal Replacement Therapies (CRRT) ConsumablesSwansea Bay University HealthBoard · 28 Aug 2026, 13:58 BST
Value not published
same CPV family
Supply of Copper Sulphate SolutionNHS Blood and Transplant · 7 Sept 2026, 16:47 BST
Value not published
same CPV family
NP57426 Condoms & Sexual Health ProductsThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · 12 Aug 2026, 16:08 BST
£1,143,000
same CPV family
Method: tender-intelligence-v1. Values and dates are retained OCDS facts; missing source data remains unknown.
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: METROPOLITAN BOROUGH OF SOLIHULL: "SOL - Nicotine Replacement Therapy". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityMETROPOLITAN BOROUGH OF SOLIHULLScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: METROPOLITAN BOROUGH OF SOLIHULL
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for METROPOLITAN BOROUGH OF SOLIHULL. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
13Bids / Report (median)
0% of reports have one bid · Mean: 10.8 bids
Supplier ConcentrationHigh Concentration
Sigma Pharmaceuticals PLCTop vendor: 100% of attributable value
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 20 active published awards; 19 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers in this Category (CPV 33):
Supplier NameHistoric AwardsAttributable ValueAvg. Price Discount
Sigma Pharmaceuticals PLC1 win£1,400,566—
Procedure terms
Contracting AuthorityMETROPOLITAN BOROUGH OF SOLIHULL
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published10 Feb 2025, 11:56 GMT
Last source update10 Feb 2025, 11:56 GMT
Recurring procurementNot published
ClassificationNicotine substitutes
Delivery area
West Midlands (UKG32)
OCIDocds-h6vhtk-04dd2e
What is being bought
For the supply of nicotine replacement therapy to support the Solihull Specialist Cessation Service.
What changed
From the official release history
  1. Status changed to complete
    10 Feb 2025, 11:56 GMT
  2. Official notice release published
    10 Feb 2025, 11:56 GMT
  3. Buyer information updated
    10 Feb 2025, 11:56 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    The provision of nicotine replacement therapy to support the Specialist Smoking Cessation Service.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    10 Feb 2025, 11:56 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 19 Dec 2024, 00:00 GMT · £1,400,566
Commercial outcome and competition
Awards
Sigma Pharmaceuticals PLC
Not published · Not published · active
Contracts
SOL - Nicotine Replacement Therapy Supply 2025
£1,400,566 · signed 19 Dec 2024, 00:00 GMT · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

METROPOLITAN BOROUGH OF SOLIHULL

Contracting authority GB-FTS-134816
View buyer profile

  • METROPOLITAN BOROUGH OF SOLIHULL
    buyer

    Council House, Manor Square, Solihull, UKG32, B913QB
    kmarsh@solihull.gov.uk
    +44 1217046085

  • Sigma Pharmaceuticals PLC
    supplier

    GB-COH: 01561802
    5th Floor, Watson House, 54-60 Baker Street, London, UKI, W1U 7BU

  • Solihull Metropolitan Borough Council
    reviewBody

    Solihull
    procteam@solihull.gov.uk
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleExtensive benchmarking activity has shown Sigma Pharmaceuticals is the most suitable and cost effective provider within a limited market.